Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 31

1.

C-reactive protein and vein graft disease: evidence for a direct effect on smooth muscle cell phenotype via modulation of PDGF receptor-beta.

Ho KJ, Owens CD, Longo T, Sui XX, Ifantides C, Conte MS.

Am J Physiol Heart Circ Physiol. 2008 Sep;295(3):H1132-H1140. doi: 10.1152/ajpheart.00079.2008.

2.

Airway lipoxin A4 generation and lipoxin A4 receptor expression are decreased in severe asthma.

Planagumà A, Kazani S, Marigowda G, Haworth O, Mariani TJ, Israel E, Bleecker ER, Curran-Everett D, Erzurum SC, Calhoun WJ, Castro M, Chung KF, Gaston B, Jarjour NN, Busse WW, Wenzel SE, Levy BD.

Am J Respir Crit Care Med. 2008 Sep 15;178(6):574-82. doi: 10.1164/rccm.200801-061OC.

3.

Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators.

Merched AJ, Ko K, Gotlinger KH, Serhan CN, Chan L.

FASEB J. 2008 Oct;22(10):3595-606. doi: 10.1096/fj.08-112201.

4.

Resolvin E1, an EPA-derived mediator in whole blood, selectively counterregulates leukocytes and platelets.

Dona M, Fredman G, Schwab JM, Chiang N, Arita M, Goodarzi A, Cheng G, von Andrian UH, Serhan CN.

Blood. 2008 Aug 1;112(3):848-55. doi: 10.1182/blood-2007-11-122598.

5.

Early remodeling of lower extremity vein grafts: inflammation influences biomechanical adaptation.

Owens CD, Rybicki FJ, Wake N, Schanzer A, Mitsouras D, Gerhard-Herman MD, Conte MS.

J Vasc Surg. 2008 Jun;47(6):1235-42. doi: 10.1016/j.jvs.2008.01.009.

6.

Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators.

Serhan CN, Chiang N, Van Dyke TE.

Nat Rev Immunol. 2008 May;8(5):349-61. doi: 10.1038/nri2294. Review.

7.

Human CMV infection induces 5-lipoxygenase expression and leukotriene B4 production in vascular smooth muscle cells.

Qiu H, Strååt K, Rahbar A, Wan M, Söderberg-Nauclér C, Haeggström JZ.

J Exp Med. 2008 Jan 21;205(1):19-24. doi: 10.1084/jem.20070201.

8.

Mediator lipidomics: search algorithms for eicosanoids, resolvins, and protectins.

Serhan CN, Lu Y, Hong S, Yang R.

Methods Enzymol. 2007;432:275-317.

PMID:
17954222
9.

Treatment of inflammatory diseases by selective eicosanoid inhibition: a double-edged sword?

Yedgar S, Krimsky M, Cohen Y, Flower RJ.

Trends Pharmacol Sci. 2007 Sep;28(9):459-64. Review.

PMID:
17692394
10.

Modulation of human airway smooth muscle migration by lipid mediators and Th-2 cytokines.

Parameswaran K, Radford K, Fanat A, Stephen J, Bonnans C, Levy BD, Janssen LJ, Cox PG.

Am J Respir Cell Mol Biol. 2007 Aug;37(2):240-7.

PMID:
17431098
11.

Resolution of inflammation: state of the art, definitions and terms.

Serhan CN, Brain SD, Buckley CD, Gilroy DW, Haslett C, O'Neill LA, Perretti M, Rossi AG, Wallace JL.

FASEB J. 2007 Feb;21(2):325-32. Review.

12.

Resolvin D1 and its aspirin-triggered 17R epimer. Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation.

Sun YP, Oh SF, Uddin J, Yang R, Gotlinger K, Campbell E, Colgan SP, Petasis NA, Serhan CN.

J Biol Chem. 2007 Mar 30;282(13):9323-34.

13.

Systemic infections and inflammation affect chronic neurodegeneration.

Perry VH, Cunningham C, Holmes C.

Nat Rev Immunol. 2007 Feb;7(2):161-7. Review.

PMID:
17220915
14.

Formyl peptide receptors and the regulation of ACTH secretion: targets for annexin A1, lipoxins, and bacterial peptides.

John CD, Sahni V, Mehet D, Morris JF, Christian HC, Perretti M, Flower RJ, Solito E, Buckingham JC.

FASEB J. 2007 Apr;21(4):1037-46.

15.

Elevated C-reactive protein levels are associated with postoperative events in patients undergoing lower extremity vein bypass surgery.

Owens CD, Ridker PM, Belkin M, Hamdan AD, Pomposelli F, Logerfo F, Creager MA, Conte MS.

J Vasc Surg. 2007 Jan;45(1):2-9; discussion 9.

16.

Augmentation of myocardial production of 15-epi-lipoxin-a4 by pioglitazone and atorvastatin in the rat.

Birnbaum Y, Ye Y, Lin Y, Freeberg SY, Nishi SP, Martinez JD, Huang MH, Uretsky BF, Perez-Polo JR.

Circulation. 2006 Aug 29;114(9):929-35.

17.

The immune response in atherosclerosis: a double-edged sword.

Hansson GK, Libby P.

Nat Rev Immunol. 2006 Jul;6(7):508-19. Review.

PMID:
16778830
18.

Lipoxin A(4) regulates bronchial epithelial cell responses to acid injury.

Bonnans C, Fukunaga K, Levy MA, Levy BD.

Am J Pathol. 2006 Apr;168(4):1064-72.

19.

Aspirin has a gender-dependent impact on antiinflammatory 15-epi-lipoxin A4 formation: a randomized human trial.

Chiang N, Hurwitz S, Ridker PM, Serhan CN.

Arterioscler Thromb Vasc Biol. 2006 Feb;26(2):e14-7.

20.

Leukotriene B4 signaling through NF-kappaB-dependent BLT1 receptors on vascular smooth muscle cells in atherosclerosis and intimal hyperplasia.

Bäck M, Bu DX, Bränström R, Sheikine Y, Yan ZQ, Hansson GK.

Proc Natl Acad Sci U S A. 2005 Nov 29;102(48):17501-6.

Items per page

Supplemental Content

Support Center